Elena Ridloff
CFO
Board Member
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sionna Therapeutics, Inc. (SION) | C.F.A. Chief Financial Officer | $506,677 | $2,857,367 |
| 2024 | Sionna Therapeutics, Inc. (SION) | C.F.A. Chief Financial Officer and Head of Corporate Development | $449,946 | $1,300,647 |
| 2023 | Sionna Therapeutics, Inc. (SION) | C.F.A. Chief Financial Officer and Head of Corporate Development | $432,640 | $623,002 |
| 2021 | Acadia Pharmaceuticals Inc (ACAD) | Chief Financial Officer | $398,871 | $2,389,704 |
| 2020 | Acadia Pharmaceuticals Inc (ACAD) | Chief Financial Officer | $462,000 | $2,514,170 |
| 2019 | Acadia Pharmaceuticals Inc (ACAD) | Chief Financial Officer | $444,026 | $1,990,867 |
Executive changes
Earnings-call appearances
-
Acadia Pharmaceuticals Inc Q2 FY2021 Earnings Call2021-08-04
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q1 FY2021 Earnings Call2021-05-05
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q4 FY2020 Earnings Call2021-02-24
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q3 FY2020 Earnings Call2020-11-04
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q2 FY2020 Earnings Call2020-08-05
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q1 FY2020 Earnings Call2020-05-07
Acadia Pharmaceuticals Inc (ACAD)